J.P. Morgan predicts what’s next for health care, Medicare | Official Website of Louis Velazquez, entrepreneur, finance guy and tech innovator

Medicare enrollees and near‑retirees get a clear warning in J.P. Morgan’s latest health care report: the rules of the game are changing.

The firm’s recap of its 44th annual Healthcare Conference lays out five trends for 2026, from AI in hospitals to political fights over what Medicare will and won’t pay for, according to “Five trends shaping healthcare in 2026” from J.P. Morgan.

“We’re set for an active year ahead — biopharma innovation, medtech and life science breakthroughs, and AI transforming health care services,” said J.P. Morgan’s health care investment banking team in the conference summary, adding that they “anticipate strong 4Q25 momentum to carry through to 2026 for both M&A and the capital markets across the entire healthcare landscape.”

I read that as a warning that money is going to keep flowing into the parts of health care that can prove value to Medicare and private insurers, and away from those that can’t.

J.P. Morgan says technology will change Medicare.

Photo by SDI Productions on Getty Images

How J.P. Morgan says technology will change Medicare

J.P. Morgan puts technology at the center of its 2026 story, and a big part of that is how Medicare and other public programs will use data.

Keynote speakers from government agencies “made the case for greater data integration in the public sector, as well as the launch of a ‘health tech ecosystem’ that can provide Medicare enrollees easier access to innovative health technologies,” according to J.P. Morgan’s conference write‑up.

The report notes that technology‑enabled care remains a clear priority, with “virtual care growing in fields like chronic care management” and digital tools increasingly used to manage expensive, long‑term conditions. Government organizations are aiming “to move faster in 2026, focusing on digital‑first solutions across drug development, data management, and diagnostics.”

From a Medicare patient’s perspective, that means more of your care could happen through remote monitoring, online visits, and AI‑assisted tools that are integrated into what Medicare actually covers, instead of sitting on the fringes as cash‑pay services.

Five trends J.P. Morgan says will define 2026

Here’s how J.P. Morgan identifies what’s coming next for health care and, indirectly, for Medicare and the taxpayers behind it.

AI and data: The conference takeaway is that 2026 will be a year when AI moves from buzzword to measurable results in health care services.
Biopharma and medtech: Biopharma innovation and life‑science breakthroughs are expected to stay in focus, with medtech companies pushing new devices and diagnostics into mainstream care.
M&A and capital markets: Headwinds could drive “strong 4Q25 momentum” in deals and capital raising into 2026, affecting which companies can scale treatments for which Medicare pays.
Health tech ecosystem: Government officials are promoting a “health tech ecosystem” designed to connect Medicare enrollees with approved digital tools and technologies.
Policy uncertainty: The firm flags expiring Affordable Care Act subsidies, the Trump administration’s health care outline, and open questions about what Medicaid and Medicare will cover as major wild cards for 2026. Source: J.P. Morgan

To me, those five themes add up to a simple message: If a drug, device, or service can’t show it saves money or improves outcomes for public payers like Medicare, it will struggle to stand out in this environment.

What J.P. Morgan says about political and Medicare uncertainty

Beyond technology and Wall Street, J.P. Morgan spends real time on the political risks that could hit your benefits and costs.

“The political battle over expiring ACA subsidies, the Trump administration’s proposed outline for health care, and the ongoing political question of what Medicaid and Medicare will (and will not) cover all make 2026 a year of potential upheaval,” the firm wrote in its conference trends piece.

In response, “health systems report prioritizing resilience and adaptability to weather any upcoming changes,” according to J.P. Morgan’s summary of provider conversations.

More Health Care:

The report goes on to say that the U.S. system still faces long‑term structural challenges, including “nursing and provider shortages, high turnover, unreliable care for rural populations, and an aging population.”

If you’re on Medicare or heading there, that combination means the benefits you see on paper can shift quickly, depending on how Washington resolves coverage questions and how hospitals adapt to staffing and cost pressures.

J.P. Morgan’s tone makes it clear that providers are planning for turbulence, not a quiet status quo.

J.P. Morgan sees these as the real health care pressure points

J.P. Morgan’s outlook makes it clear that 2026 isn’t just about shiny new tech; it’s about whether the system can cope with deep, long‑running strains. The firm highlights four pressure points it sees shaping strategy.

Workforce: Nursing and provider shortages and “high turnover” are cited as long‑term headwinds that affect everything from wait times to the services hospitals can offer.
Rural access: The report flags “unreliable care for rural populations” as an ongoing challenge, with virtual care seen as one way to partially close that gap.
Aging population: An aging U.S. population is increasing demand for Medicare‑funded care, just as budgets come under scrutiny.
Policy swings: The combination of ACA subsidy fights and Trump‑era health care proposals creates “a year of potential upheaval” for coverage and reimbursement. Source: J.P. Morgan

How providers are planning around Medicare and Medicaid risk

Health systems and other providers are not waiting to see what Congress or CMS do; they’re adjusting business models now, as seen in J.P. Morgan’s piece.

“Health systems report prioritizing resilience and adaptability to weather any upcoming changes,” the conference summary said, pointing to diversification of revenue and investments in tech as common themes.

While the J.P. Morgan article is broad, it sits against a backdrop of Medicare pushing value‑based models and risk‑sharing arrangements, something other 2026 commentary has also flagged.

Analysts at Bradley Arant, covering the same conference season, said stakeholders “broadly expect continued challenges for value-based care providers with direct Medicare Advantage exposure in 2026,” particularly where they’ve taken on “meaningful downside risk amid budget uncertainty and accelerating pharmacy spend.”

To me, that lines up with J.P. Morgan’s focus: Medicare isn’t stepping back from the idea of paying for outcomes instead of just visits.

It’s leaning into models that tie provider revenue more tightly to keeping seniors healthier at lower cost, even if that creates short‑term pain for some operators.

What this means if you’re a patient, investor, or operator

When I put J.P. Morgan’s health care and Medicare signals together, I don’t see a calm, incremental year; I see 2026 as a stress test for which models actually work.

For patients, especially Medicare enrollees, the near‑term story is more technology in your care, more virtual options, and more behind‑the‑scenes experimentation with how services are paid for, according to J.P. Morgan’s conference analysis.

For investors and operators, the bank is essentially saying the playing field is shifting toward businesses that can deliver measurable outcomes in an environment of staffing shortages, political uncertainty, and an aging population.

“We’re set for an active year ahead,” J.P. Morgan’s health care team said, pointing to biopharma, medtech, life science tools, and AI‑powered services as key areas where capital will flow.

You’re not just watching for new miracle drugs or headline‑grabbing hospital deals. You’re watching to see which companies can prove to Medicare and other payers that their technology or service actually moves the needle on cost and quality, because that’s where the next decade of health care money and policy seems to be heading.